Overview
Wenqin Liu practices practicing medicine in Dongguan, China.
Their clinical expertise encompasses Pelvic Inflammatory Disease, Seborrheic Keratosis, Renal Cell Carcinoma (RCC), and Fibrosarcoma.
They are actively involved in clinical research, co-authoring 25 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Wenqin Liu
Is Wenqin Liu a top-rated expert for Pelvic Inflammatory Disease?
MediFind is an objective health platform that identifies experts based on real-world data. Wenqin Liu is classified as an Experienced expert for Pelvic Inflammatory Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Wenqin Liu participate in research or clinical trials?
Yes. Wenqin Liu has published 25 articles and abstracts on conditions like Pelvic Inflammatory Disease. You can view a list of Wenqin Liu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- EndometritisLiu isExperienced. Learn about Endometritis.
- FibrosarcomaLiu isExperienced. Learn about Fibrosarcoma.
- Pelvic Inflammatory Disease
- Renal Cell Carcinoma (RCC)
- Seborrheic KeratosisLiu isExperienced. Learn about Seborrheic Keratosis.